Merit Medical Systems, Inc. (MMSI) Stake Lowered by Martin & Co. Inc. TN

Martin & Co. Inc. TN reduced its holdings in Merit Medical Systems, Inc. (NASDAQ:MMSI) by 15.1% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 45,320 shares of the medical instruments supplier’s stock after selling 8,075 shares during the quarter. Martin & Co. Inc. TN owned approximately 0.09% of Merit Medical Systems worth $1,919,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also made changes to their positions in the company. Advisors Asset Management Inc. boosted its holdings in shares of Merit Medical Systems by 28.2% in the 2nd quarter. Advisors Asset Management Inc. now owns 3,723 shares of the medical instruments supplier’s stock worth $142,000 after acquiring an additional 820 shares in the last quarter. Ameritas Investment Partners Inc. boosted its holdings in shares of Merit Medical Systems by 20.9% in the 2nd quarter. Ameritas Investment Partners Inc. now owns 4,272 shares of the medical instruments supplier’s stock worth $163,000 after acquiring an additional 738 shares in the last quarter. SG Americas Securities LLC acquired a new position in shares of Merit Medical Systems in the 3rd quarter worth approximately $189,000. Riverhead Capital Management LLC boosted its holdings in shares of Merit Medical Systems by 67.7% in the 2nd quarter. Riverhead Capital Management LLC now owns 5,198 shares of the medical instruments supplier’s stock worth $198,000 after acquiring an additional 2,098 shares in the last quarter. Finally, Flinton Capital Management LLC boosted its holdings in shares of Merit Medical Systems by 67.4% in the 2nd quarter. Flinton Capital Management LLC now owns 5,236 shares of the medical instruments supplier’s stock worth $200,000 after acquiring an additional 2,108 shares in the last quarter. 90.89% of the stock is currently owned by institutional investors and hedge funds.

Merit Medical Systems, Inc. (NASDAQ:MMSI) opened at $43.65 on Wednesday. The company has a quick ratio of 1.43, a current ratio of 2.78 and a debt-to-equity ratio of 0.39. Merit Medical Systems, Inc. has a 1 year low of $24.23 and a 1 year high of $45.50. The firm has a market cap of $2,176.12, a P/E ratio of 34.13, a P/E/G ratio of 2.94 and a beta of 1.23.

Merit Medical Systems (NASDAQ:MMSI) last posted its quarterly earnings data on Wednesday, October 25th. The medical instruments supplier reported $0.32 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.02. Merit Medical Systems had a net margin of 4.06% and a return on equity of 9.86%. The firm had revenue of $179.30 million during the quarter, compared to analysts’ expectations of $181.28 million. During the same quarter in the previous year, the company posted $0.26 EPS. Merit Medical Systems’s revenue was up 14.2% on a year-over-year basis. analysts expect that Merit Medical Systems, Inc. will post 1.27 earnings per share for the current fiscal year.

In related news, Director Kent W. Stanger sold 2,918 shares of the business’s stock in a transaction that occurred on Thursday, November 30th. The shares were sold at an average price of $44.55, for a total value of $129,996.90. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 5.00% of the company’s stock.

MMSI has been the topic of several recent analyst reports. Canaccord Genuity boosted their target price on Merit Medical Systems from $45.00 to $47.50 and gave the stock a “buy” rating in a report on Thursday, October 26th. SunTrust Banks set a $47.00 target price on Merit Medical Systems and gave the stock a “buy” rating in a report on Thursday, November 16th. ValuEngine raised Merit Medical Systems from a “hold” rating to a “buy” rating in a report on Tuesday, November 21st. Zacks Investment Research downgraded Merit Medical Systems from a “buy” rating to a “hold” rating in a report on Tuesday, October 3rd. Finally, BidaskClub downgraded Merit Medical Systems from a “hold” rating to a “sell” rating in a report on Tuesday, December 5th. One investment analyst has rated the stock with a sell rating, two have given a hold rating and eleven have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and a consensus price target of $43.77.

WARNING: “Merit Medical Systems, Inc. (MMSI) Stake Lowered by Martin & Co. Inc. TN” was first published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another domain, it was illegally stolen and reposted in violation of US and international trademark & copyright legislation. The legal version of this article can be read at https://www.dispatchtribunal.com/2017/12/13/merit-medical-systems-inc-mmsi-stake-lowered-by-martin-co-inc-tn.html.

About Merit Medical Systems

Merit Medical Systems, Inc is a manufacturer and marketer of disposable medical devices used in a range of interventional, diagnostic and therapeutic medical procedures. The Company operates in two segments: cardiovascular and endoscopy. The cardiovascular segment consists of cardiology and radiology devices, which assist in diagnosing and treating coronary arterial disease, peripheral vascular disease and other non-vascular diseases, and includes embolotherapeutic, cardiac rhythm management (CRM), electrophysiology (EP), and interventional oncology and spine devices.

Institutional Ownership by Quarter for Merit Medical Systems (NASDAQ:MMSI)

Receive News & Ratings for Merit Medical Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Merit Medical Systems and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply